Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review

Schizophrenia Bulletin

Volumn 33, Issue 6, 2007, Pages 1324-1342

  Lincoln, Tania M ^a   Lüllmann, Eva ^a   Rief, Winfried ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Adherence; Course of symptoms; Depression; Functional outcome; Insight

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT; TRANQUILIZER;

AGGRESSION; ARTICLE; BEHAVIOR; COGNITIVE THERAPY; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; FUNCTIONAL ASSESSMENT; HOSPITALIZATION; HUMAN; INTROSPECTION; LONGITUDINAL STUDY; MENTAL FUNCTION; MENTAL PATIENT; MOTIVATION; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; PSYCHOSIS; PSYCHOTHERAPY; QUESTIONNAIRE; SCHIZOPHRENIA; SOCIAL STATUS; SUICIDE; SYMPTOM; SYSTEMATIC REVIEW;

COGNITION DISORDERS; DEPRESSION; HUMANS; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 35649028046     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbm002     Document Type: Article

References (115)

1. Jones C, Cormac I, Silveira da Mota Neto JI, Campbell C. Cognitive therapy for schizophrenia. Cochrane Database Syst Rev. 2004;4:1-57.
2. Leucht S, Pitschel-Walz G, Abraham D, Kissling W. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials. Schizophr Res. 1999;35:51-68.
3. Wallace C, Mullen P, Burgess P. Criminal offending in schizophrenia over a 25-year period marked by deinstitutionalization and increasing prevalence of comorbid substance use disorders. Am J Psychiatry. 2004;161:716-727.
4. Wiersma D, Wanderling J, Dragomirecka E, et al. Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European countries. Psychol Med. 2000;30:1155-1167.
5. Sevy S, Nathanson K, Visweswaraiah H, Amador X. The relationship between insight and symptoms in schizophrenia. Compr Psychiatry. 2004;45:16-19.
6. Dickerson FB, Boronow JJ, Ringel N, Parente F. Lack of insight among outpatients with schizophrenia. Psychiatr Serv. 1997;48:195-199.
7. Lysaker P, Bryson GJ, Bell M. Insight and work performance in schizophrenia. J Nerv Ment Dis. 2002;190:142-146.
8. Gharabawi GM, Lasser RA, Bossie CA, Zhu Y, Amador X. Insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidone. Int Clin Psychopharmacol. 2006;21:233-240.
9. McGlashan TH, Carpenter WTJ. Postpsychotic depression in schizophrenia. Arch Gen Psychiatry. 1976;33:231-239.
10. Bjørkly S. Empirical evidence of a relationship between insight and risk of violence in the mentally ill - a review of the literature. Aggress Violent Behav. 2006;11:414-423.
11. Pompili M, Ruberto A, Kotzalidis G, Girardi P, Tatarelli R. Suicide and awareness of illness in schizophrenia: an overview. Bull Menninger Clin. 2004;68:297-318.
12. Amador XF, Strauss DH, Yale SA, Gorman JM. Awareness of illness in schizophrenia. Schizophr Bull. 1991;17:113-132.
13. Schwartz RC. The relationship between insight, illness and treatment outcome in schizophrenia. Psychiatr Q. 1998;69:1-22.
14. Lewis L. Mourning, insight reduction of suicide risk in schizophrenia. Bull Menninger Clin. 2004;68:231-244.
15. Dam J. Insight in schizophrenia: a review. Nordic J Psychiatry. 2006;60:114-120.
16. McEvoy JP. The relationship between insight into psychosis and compliance with medications. In: Amador X, David A, eds. Insight and Psychosis. Awareness of Illness in Schizophrenia and Related Disorders. Oxford: University Press; 2004:311-333.
17. Torrey EF. The relationship of insight to violent behaviour and stigma. In: Amador X, David A, eds. Insight and Psychosis. Awareness of Illness in Schizophrenia and Related Disorders. Oxford, England: University Press; 2004:243-256.
18. Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry. 1978;35:837-844.
19. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
20. Wing JK, Cooper JE, Sartorius N. Measurement and classification of psychiatric symptoms: an instruction manual for the PSE and catego programme. Cambridge, England: Cambridge University Press; 1974.
21. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr Bull. 1987;13:261-276.
22. AMDP. Das AMDP-System. Manual zur Dokumentation Psychiatrischer Befunde. Goettingen, Germany: Hogrefe; 2000.
23. David AS. Insight and psychosis. Br J Psychiatry. 1990;156:798-808.
24. Soskis DA, Bowers MB. The schizophrenic experience. A follow-up study of attitude and post hospital adjustment. J Nerv Ment Dis. 1969;149:443-449.
25. Davidhizar RE. Beliefs, feelings and insight of patients with schiozophrenia about taking medication. J Adv Nurs. 1987;12:177-182.
26. McEvoy JP, Apperson LJ, Applebaum PS, et al. Insight in schizophrenia. Its relationship to acute psychopathology. J Nerv Ment Dis. 1989;177:43-47.
27. Sanz M, Constable G, Lopez-Ibor I, Kemp R, David AS. A comparative study of insight scales and their relationship to psychopathological and clinical variables. Psychol Med. 1998;28:437-446.
28. David A, Buchanan A, Reed A, Almeida O. The assessment of insight in psychosis. Br J Psychiatry. 1992;161:599-602.
29. Marková I, Berrios GE. The assessment of insight in clinical psychiatry: a new scale. Acta Psychiatr Scand. 1992;86:159-164.
30. Marková I, Berrios GE. Insight in clinical psychiatry. J Nerv Ment Dis. 1995;183:743-751.
31. Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J, Gorman JM. The assessment of insight in psychosis. Am J Psychiatry. 1993;150:873-879.
32. Kemp RA, Lambert TJ. Insight in schizophrenia and its relationship to psychopathology. Schizophr Res. 1995;18:21-28.
33. Cuesta MJ, Peralta V, Zarzuela A. Reappraising insight in psychosis: multi-scale longitudinal study. Br J Psychiatry. 2000;177:233-240.
34. Birchwood M, Smith J, Drury V, Healy J, MacMillian F, Slade MA. A self-report insight scale for psychosis: reliability, validity, and sensitivity to change. Acta Psychiatr Scand. 1994;89:62-67.
35. Young DA, Campbell Z, Zakzanis KK, Weinstein E. A comparison between an interview and a self-report method of insight assessment in chronic schizophrenia. Schizophr Res. 2003;63:103-109.
36. Cuffel BJ, Alford J, Fischer EP, Owen RR. Awareness of illness in schizophrenia and outpatient treatment adherence. J Nerv Ment Dis. 1996;184:653-659.
37. De?bowska G, Grzywa A, Kucharska-Pietura K. Insight in paranoid schizophrenia - its relationship to psychopathology and premorbid adjustment. Compr Psychiatry. 1998;39:255-260.
38. Eisen JL, Philipps KA, Baer L, Beer DA, Atala KD, Rasmussen SA. The Brown Assessment of Beliefs Scale: reliability and validity. Am J Psychiatry. 1998;155:102-108.
39. Kaplan GB, Phillips KA, Vaccaro A, Eisen JE. Assessment of insight into delusional beliefs in schizophrenia using the Brown Assessment of Beliefs Scale. Schizophr Res. 2006;82:279-281.
40. Marks KA, Fastenau PS, Lysaker PH, Bond GR. Self-Appraisal of Illness Questionnaire (SAIQ): relationship to researcher-rated insight and neuropsychological function in schizophrenia. Schizophr Res. 2000;45:203-211.
41. Beck A-T, Baruch E, Balter JM, Steer RA, Warman DM. A new instrument for measuring insight: the Beck Cognitive Insight Scale. Schizophr Res. 2003;68:319-329.
42. Pedrelli P, McQuaid JR, Granholm E, et al. Measuring cognitive insight in middle-aged and older patients with psychotic disorders. Schizophr Res. 2004;71:297-305.
43. Amador X, Kronengold H. Understanding and assessing insight. In: Amador X, David A, eds. Insight and Psychosis. Awareness of Illness in Schizophrenia and Related Disorders. Oxford, England: University Press; 2004.
44. Macpherson R, Jerrom B, Hughes A. Drug refusal among schizophrenic patients treated in the community. J Ment Health. 1997;6:141-147.
45. Smith TE, Hull JW, Goodman M, et al. The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder. J Nerv Ment Dis. 1999;187:102-108.
46. Coldham EL, Addington J, Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand. 2002;106:286-290.
47. Kozuki Y, Froelicher ES. Lack of awareness and nonadherence in schizophrenia. West J Nurs Res. 2003;25:57-74.
48. Yen C-F, Chen C-S, Ko C-H, et al. Relationships between insight and medication adherence in outpatients with schizophrenia an bipolar disorder: a prospective study. Psychiatry Clin Neurosci. 2005;59:403-409.
49. Watson PWP, Garety PA, Weinman J, et al. Emotional dysfunction in schizophrenia spectrum psychosis: the role of illness perceptions. Psychol Med. 2006;36:761-770.
50. Mutsata SH, Joyce EM, Hutton SB, et al. Clinical correlates of early medication adherence: West London first episode schizophrenia study. Acta Psychiatr Scand. 2003;108:439-446.
51. Donohoe G, Owens N, O'Donnell C, et al. Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analyses. Eur Psychiatry. 2001;16:293-298.
52. Smith CM, Barzman D, Pristach CA. Effect of patient and family insight on compliance of schizophrenic patients. J Clin Pharmacol. 1997;37:147-154.
53. Moore A, Sellwood W, Stirling J. Compliance and psychological reactance in schizophrenia. Br J Clin Psychol. 2000;39:287-295.
54. Kamali M, Kelly L, Gervin M, Browne S, Larkin C, O'Callaghan E. Insight and comorbid substance misuse and medication compliance among patients with schizophrenia. Psychiatr Serv. 2001;52:161-166.
55. Agarwal MR, Sharma VK, Kumar K, Lowe D. Noncompliance with treatment in patients suffering from schizophrenia: a study to evaluate possible contributing factors. Int J Soc Psychiatry. 1998;44:92-106.
56. Garavan J, Browne S, Gervin M, Lane A, Larkin C, O'Callaghan E. Compliance with neuroleptic medication in outpatients with schizoprenia; relationship to subjective response to neuroleptics; attitudes to medication and insight. Compr Psychiatry. 1998;39:215-219.
57. Day JC, Bentall R, Roberts C, et al. Attitudes toward antipsychotic medication - the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry. 2005;62:717-724.
58. McEvoy JP, Freter S, Everett G, et al. Insight and the clinical outcome of schizophrenic patients. J Nerv Ment Dis. 1989;177:48-51.
59. Buchanan A. A two-year prospective study of treatment compliance in patients with schizophrenia. Psychol Med. 1992;22:789-797.
60. Novak-Grubic V, Tavcar R. Predictors of noncompliance in males with first-episode schizophrenia, schizophreniform and schizoaffective disorder. Eur Psychiatry. 2002;17:148-154.
61. Tait L, Birchwood M, Trower P. Predicting engagement with services for psychosis: insight, symptoms and recovery style. Br J Psychiatry. 2003;182:123-128.
62. Byerly MJ, Fischer R, Carmody T, Rush AJ. A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2005;66:997-1001.
63. Kamali M, Kelly BD, Clarke M, et al. A prospective evaluation of adherence to medication in first episode schizophrenia. Eur Psychiatry. 2006;21:29-33.
64. Bhanji NH, Chouinard G, Margolese HC. A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia. Eur Neuropsychopharmacol. 2004;14:87-92.
65. Pitschel-Walz G, Bäuml J, Bender W, Engel RR, Wagner M, Kissling W. Psychoeducation and compliance in the treatment of schizophrenia: results of the Munich Psychosis Information Project Study. J Clin Psychiatry. 2006;67:443-452.
66. Zygmund A, Olfson M, Boyer CA, Mechanic D. Interventions to improve medication adherence in schizophrenia. Am J Psychiatry. 2002;159:1653-1664.
67. Ziguras SJ, Stuart GW. A meta-analysis of the effectiveness of mental health case management over 20 years. Psychiatr Serv. 2000;51:1410-1421.
68. Jørgensen P. Recovery and insight in schizophrenia. Acta Psychiatr Scand. 1995;92:436-440.
69. Weiler MA, Fleisher MH, McArthur-Campbell D. Insight and symptom change in schizophrenia and other disorders. Schizophr Res. 2000;45:29-36.
70. Michalakes A, Skoutas C, Charalambous A, et al. Insight in schizophrenia and mood disorders and its relation to psychopathology. Acta Psychiatr Scand. 1994;90:46-49.
71. Mintz AR, Dobson KS, Romney DM. Insight in schizophrenia: a meta-analysis. Schizophr Res. 2003;61:75-88.
72. McEvoy JP, Freter S, Merritt M, Apperson LJ. Insight about psychosis among outpatients with schizophrenia. Hosp Community Psychiatry. 1993;44:883-884.
73. Smith TE, Hull JW, Santos L. The relationship between symptoms and insight in schizophrenia: a longitudinal perspective. Schizophr Res. 1998;33:63-67.
74. Chen EY-H. Insight and symptoms of psychosis: a prospective inpatient study. Schizophr Res. 1998;29:34.
75. Carroll A, Fattah S, Clyde Z, Coffey I, Owens DGC, Johnstone EC. Correlates of insight and insight change in schizophrenia. Schizophr Res. 1999;35:247-253.
76. Yen C-F, Yeh M-L, Chen C-S, Chung H-H. Predictive value of insight for suicide, violence, hospitalization, and social adjustment for outpatients with schizophrenia: a prospective study. Compr Psychiatry. 2002;43:443-447.
77. Mintz AR, Addington J, Addington D. Insight in early psychosis: a 1-year follow-up. Schizophr Res. 2004;67:213-217.
78. Simon AE, Berger GE, Giacomini V, Ferrero F, Mohr S. Insight in relation to psychosocial adjustment in schizophrenia. J Nerv Ment Dis. 2004;192:442-445.
79. Schwartz RC, Cohen BN, Grubaugh A. Does insight affect long-term inpatient treatment outcome in chronic schizophrenia? Compr Psychiatry. 1997;38:283-288.
80. McGlashan TH, Carpenter WT. Does attitude toward psychosis relate to outcome? Am J Psychiatry. 1981;150:1649-1653.
81. Amador XF, Flaum MM, Andreasen NC, et al. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry. 1994;51:826-836.
82. Rossi A, Arduini L, Prosperini P, Kalyvoka A, Stratta P, Daneluzzo E. Awareness of illness and outcome in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2000;250:73-75.
83. Chen KC, Chu CL, Yang YK, et al. The relationship among insight, cognitive function of patients with schizophrenia and their relatives' perception. Psychiatry Clin Neurosci. 2005;59:657-660.
84. Lysaker P, Bell M. Work rehabilitation and improvements in insight in schizophrenia. J Nerv Ment Dis. 1995;183:103-106.
85. Schwartz RC. Self-awareness in schizophrenia: its relationship to depressive symptomatology and broad psychiatric impairments. J Nerv Ment Dis. 2001;189:401-403.
86. White R, Bebbington P, Pearson J, Johnson S, Ellis D. The social context of insight in schizophrenia. Soc Psychiatry Psychiatr Epidemiol. 2000;35:500-507.
87. Baier M, DeShay E, Owens K, et al. The relationship between insight and clinical factors for persons with schizophrenia. Arch Psychiatr Nurs. 2000;14:259-265.
88. Cuesta MJ, Peralta V. Lack of insight in schizophrenia. Schizophr Bull. 1994;20:359-366.
89. Lysaker P, Bell M, Milstein R, Bryson G, Beam-Goulet J. Insight and psychosocial treatment compliance in schizophrenia. Psychiatry. 1994;57:307-315.
90. Arango C, Bombín I, González-Salvador T, García-Cabeza I, Bobes J. Randomised clinical trial comparing oral versus depot formulations of zuclopenthixol in patients with schizophrenia and previous violence. Eur Psychiatry. 2006;21:34-40.
91. Arango C, Barba AC, González-Salvador T, Ordóñez AC. Violence in inpatients with schizophrenia: a prospective study. Schizophr Bull. 1999;25:493-503.
92. Buckley PF, Hrouda DR, Freeman L, Noffsinger SG, Resnick PJ, Camlin-Shinger MSSA. Insight and its relationship to violent behavior in patients with schizophrenia. Am J Psychiatry. 2004;161:1712-1714.
93. Strand S, Belfrage H, Fransson G, Levander S. Clinical and risk management factors in risk prediction of mentally disordered offenders-more important than historical data? Legal Criminol Psychol. 1999;4:67-76.
94. Grevatt A, Thomas-Peter B, Hughes G. Violence, mental disorder and risk assessment: can structured clinical assessments predict the short-term risk of inpatient violence? J Forensic Psychiatry Psychol. 2004;15:278-292.
95. Foley S, Kelly BD, Clarke M, et al. Incidence and clinical correlates of aggression and violence at presentation in patients with first episode psychosis. Schizophr Res. 2005;72:161-168.
96. Cheung P, Schweitzer I, Crowley K, Tuckwell V. Violence in schizophrenia: role of hallucinations and delusions. Schizophr Res. 1997;26:181-190.
97. Swartz MS, Swanson JW, Hiday VA, Borum R, Wagner R, Burns BJ. Violence and severe mental illness: the effects of substance abuse and nonadherence to medication. Am J Psychiatry. 1998;155:226-231.
98. Carroll A, Pantelis C, Harvey C. Insight and hopelessness in forensic patients with schizophrenia. Aust N Z J Psychiatry. 2004;38:169-173.
99. Sim K, Mahendran R, Siris SG, Heckers S, Chong SA. Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression. Psychiatry Res. 2004;129:141-147.
100. Schwartz RC, Smith SD. Suicidality and psychosis: the predictive potential of symptomatology and insight into illness. J Psychiatr Res. 2004;38:185-191.
101. Amador XF, Friedman JH, Kasapis C, Yale SA, Flaum M, Gorman JM. Suicidal behaviour in schizophrenia and its relationship to awareness of illness. Am J Psychiatry. 1996;153:1185-1188.
102. Schwartz RC, Petersen S. The relationship between insight and suicidality among patients with schizophrenia. J Nerv Ment Dis. 1999;187:376-378.
103. Schwartz RC. Insight and suicidality in schizophrenia: a replication study. J Nerv Ment Dis. 2000;188:235-237.
104. Evren C, Evren B. Characteristics of schizophrenic patients with a history of suicide attempt. Int J Psychiatry Clin Pract. 2004;8:227-234.
105. Kim C-H, Jayathilake K, Meltzer HY. Hopelessness, neurocognitive function. insight in schizophrenia: relationship to suicidal behavior. Schizophr Res. 2003;60:71-80.
106. Crumlish N, Whitty P, Kamali M, et al. Early insight predicts depression and attempted suicide after 4 years in first-episode schizophrenia and schizophreniform disorder. Acta Psychiatr Scand. 2005;112:449-455.
107. Drake RJ, Pickles A, Bentall RP, et al. The evolution of insight, paranoia and depression during early schizophrenia. Psychol Med. 2004;34:285-292.
108. Smith TE, Hull JW, Huppert JD, Silverstein SM, Anthony DT, McClough J. Insight and recovery from psychosis in chronic schizophrenia and schizoaffective disorder patients. J Psychiatr Res. 2004;38:169-176.
109. Iqbal Z, Birchwood M, Chadwick P, Trower P. Cognitive approach to depression and suicidal thinking in psychosis - 2. Testing the validity of a social ranking model. Br J Psychiatry. 2000;177:522-528.
110. Bourgeois M, Swendsen J, Young F, et al. Awareness of disorder and suicide risk in the treatment of schizophrenia: results of the international suicide prevention trial. Am J Psychiatry. 2004;161:1494-1496.
111. Moore O, Cassidy E, Carr A, Callaghan EO. Unawareness of illness and its relationship with depression and self-deception in schizophrenia. Eur J Psychiatry. 1999;14:264-269.
112. Pini S, Cassano GB, Dell'Osso L, Amador X. Insight into illness in schizophrenia, schizoaffective disorder, and mood disorders with psychotic features. Am J Psychiatry. 2001;158:122-125.
113. Bellack AS. Scientific and consumer models of recovery in schizophrenia: concordance, contrasts, and implications. Schizophr Bull. 2006;32:423-442.
114. Lysaker P, Campbell K, Johannesen JK. Hope, awareness of Illness. coping in schizophrenia spectrum disorders - evidence of an interaction. J Nerv Ment Dis. 2005;193:287-292.
115. Fowler D, Garety P, Kuipers E. Cognitive Behaviour Therapy for Psychosis. Theory and Practice. Wiley Series in Clinical Psychology. Chichester, England: Wiley; 1995.